MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 125277 | Name: Phencarbamide napadisilate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Phencarbamide is an anti-spasmodic and anticholinergic drug used during parturition.

Chemical Structure

Phencarbamide napadisilate
Phencarbamide napadisilate
CAS#72017-58-4 (napadisilate)

Theoretical Analysis

MedKoo Cat#: 125277

Name: Phencarbamide napadisilate

CAS#: 72017-58-4 (napadisilate)

Chemical Formula: C29H32N2O7S3

Exact Mass: 616.1400

Molecular Weight: 616.76

Elemental Analysis: C, 56.48; H, 5.23; N, 4.54; O, 18.16; S, 15.59

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
58-13-9 (HCl) 3735-90-8 (free base) 72017-58-4 (napadisilate)
Synonym
Gelosedine; Phencarbamide napadisilate; Fencarbamide napadisilate; HXQ3ENP4FG; Fencarbamide 1,5-naphthalenedisulfonate
IUPAC/Chemical Name
S-(2-(diethylamino)ethyl) diphenylcarbamothioate naphthalene-1,5-disulfonate
InChi Key
ZZNARJBYZHRHKJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H24N2OS.C10H8O6S2/c1-3-20(4-2)15-16-23-19(22)21(17-11-7-5-8-12-17)18-13-9-6-10-14-18;11-17(12,13)9-5-1-3-7-8(9)4-2-6-10(7)18(14,15)16/h5-14H,3-4,15-16H2,1-2H3;1-6H,(H,11,12,13)(H,14,15,16)
SMILES Code
OS(=O)(=O)C1=CC=CC2=C(C=CC=C12)S(O)(=O)=O.CCN(CC)CCSC(=O)N(C3=CC=CC=C3)C4=CC=CC=C4
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 616.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: BOERGER HH. PHENKARBAMID, EIN NEUES SPASMOLYTIKUM IN KOMBINATION MIT DOLVIRAN [PHENCARBAMIDE, A NEW SPASMOLYTIC COMBINED WITH DOLVIRAN]. Ther Ggw. 1964 Jun;103:797-801. German. PMID: 14243633. 2: OBERSCHULTE H, RICHTER A. SPASMOLYSE IN DER GEBURTSHILFE. KLINISCHE ERFAHRUNGEN MIT PHENCARBAMID [SPASMOLYSIS IN OBSTETRICS: CLINICAL EXPERIENCE WITH PHENCARBAMIDE]. Med Welt. 1964 Sep 26;39:2086-8. German. PMID: 14303609. 3: WIRTH W. [On the pharmacology of the uterine action of phencarbamide]. Med Exp Int J Exp Med. 1963;8:107-15. German. PMID: 14001293. 4: BALKEN W. [On the clinical experiences with the spasmolytic Bayer 1355 (phencarbamide) in obstetrics]. Med Exp Int J Exp Med. 1963;8:116-24. German. PMID: 13966124. 5: Madan BR, Madan V, Pendse VK, Gupta RS. A study of the antiarrhythmic and local anaesthetic actions of phencarbamide. Arch Int Pharmacodyn Ther. 1970 May;185(1):53-65. PMID: 5470024. 6: Gupta RS, Khanna NK, Madan BR. Propranolol-bunolol and phencarbamide in chloroform-induced ventricular fibrillation in mice. Arch Int Pharmacodyn Ther. 1973 Jun;203(2):265-7. PMID: 4582610. 7: Madan BR, Gupta RS, Pendse VK, Madan V. Anticonvulsant effect of phencarbamide and its modification by reserpine and tranylcypromine. Arch Int Pharmacodyn Ther. 1971 Mar;190(1):155-8. PMID: 4994549. 8: Laurent A, Vilmer J. Dosage colorimétrique de la fencarbamide et de ses sels, chlorhydrate et naphtalène disulfonate [Colorimetric determination of phencarbamide and its hydrochloride and naphthalene disulfonate salts]. Ann Pharm Fr. 1971 Nov;29(11):569-71. French. PMID: 5138619. 9: Korte W, Beck KJ. Spasmolysewirkung von Phencarbamid auf das Collum uteri im Frühwochenbett [Spasmolytic effect of phencarbamide on the uterine cervix during early puerperium]. Med Klin. 1966 Aug 26;61(34):1341-3. German. PMID: 5995198. 10: PALM A. PRAKTISCHE ERFAHRUNGEN MIT DEM SPASMOLYTIKUM ESCORPAL IN DER GEBURTSHILFE [PRACTICAL EXPERIENCES WITH THE SPASMOLYTIC AGENT ESCORPAL IN OBSTETRICS]. Med Welt. 1965 Jan 30;19:277-8. German. PMID: 14271426.